Robert J. Hariri

Robert J. Hariri, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cryoport, Inc., Celularity Inc and Biovie Inc. The record holds 31 filings, for trades running from 16 July 2021 to 5 June 2026.

On the open market, the record shows 4 purchases worth €1.6M and 9 sales worth €266k. The net balance comes to €1.3M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 12 share grants and 5 option exercises.

In size, the median ticket on the buying side is €67k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 8 June 2026 came the latest disclosure, a share grant in Cryoport, Inc. The latest purchase dates back some time: it was published 1,104 days ago, on 10 October 2023. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.